Brief: Lipigon Pharmaceuticals Q2 Operating Profit Up At SEK 7.1 Mln
29/08/2023 07:42
Aug 29 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST :
* Q2 NET SALES SEK 16.1 MILLION VERSUS SEK 0 YEAR AGO
* Q2 OPERATING PROFIT SEK 7.1 MILLION VERSUS LOSS SEK 12.7
MILLION
YEAR AGO
Source text for Eikon: ID:nBQN3gSL9b
Further company coverage: LPGO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds